Cargando…

A Novel Coagulation Classification and Postoperative Bleeding in Severe Spontaneous Intracerebral Hemorrhage Patients on Antiplatelet Therapy

BACKGROUND AND PURPOSE: For patients with severe spontaneous intracerebral hemorrhage on antiplatelet therapy (patients with APT-SICH), postoperative rebleeding (PR) is an important cause of poor outcomes after surgery. As impacted by coagulation disorder caused by APT, patients with APT-SICH are li...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qingyuan, Li, Xiong, Wang, Nuochuan, Yang, Junhua, Wang, Kaiwen, Chen, Shanwen, Li, Jiangan, Wu, Jun, Zhang, Yanan, Wang, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888928/
https://www.ncbi.nlm.nih.gov/pubmed/35250539
http://dx.doi.org/10.3389/fnagi.2022.793129
_version_ 1784661270579904512
author Liu, Qingyuan
Li, Xiong
Wang, Nuochuan
Yang, Junhua
Wang, Kaiwen
Chen, Shanwen
Li, Jiangan
Wu, Jun
Zhang, Yanan
Wang, Shuo
author_facet Liu, Qingyuan
Li, Xiong
Wang, Nuochuan
Yang, Junhua
Wang, Kaiwen
Chen, Shanwen
Li, Jiangan
Wu, Jun
Zhang, Yanan
Wang, Shuo
author_sort Liu, Qingyuan
collection PubMed
description BACKGROUND AND PURPOSE: For patients with severe spontaneous intracerebral hemorrhage on antiplatelet therapy (patients with APT-SICH), postoperative rebleeding (PR) is an important cause of poor outcomes after surgery. As impacted by coagulation disorder caused by APT, patients with APT-SICH are likely to suffer from PR. This study aimed to assess the risk of PR in patients with APT-SICH receiving emergency surgery using a novel coagulation classification. METHODS: This prospective, multicenter cohort study consecutively selected patients with APT-SICH between September 2019 and March 2021. The preoperative coagulation factor function was recorded, and the platelet function was assessed using thrombelastography. Based on platelet and coagulation factor function, a novel four-type coagulation classification, i.e., Type I (severe coagulation disorder), Type IIa (low platelet reserve capacity), Type IIb (normal coagulation), and Type III (hypercoagulation), was presented. The primary outcome was PR, defined as the rebleeding in the operative region or new intracerebral hemorrhage correlated with the operation. RESULTS: Of the included 197 patients with APT-SICH, PR occurred in 40 patients (20.3%). The novel coagulation classification categorized 28, 32, 122, and 15 patients into Type I, Type IIa, Type IIb, and Type III, respectively. The Type I patients had the highest incident rate of PR (39.3 per 100 persons), followed by the Type IIa patients (31.3 per 100 persons). In the PR-related analysis, the large hematoma volume (hazard ratio (HR): 1.02; 95% CI: 1.02–1.03; p < 0.001), Type I (HR: 9.72; 95% CI: 1.19–79.67; p = 0.034), and Type IIa (HR: 8.70; 95% CI: 1.09–69.61; p = 0.041) were correlated with the highest risk of PR. The coagulation classification could discriminate the PR patients from no PR (NPR) patients (p < 0.001), and it outperformed the conventional coagulation assessment (only considering platelet count and coagulation factor function) (c-statistic, 0.72 vs. 0.55). CONCLUSION: The novel coagulation classification could discriminate the patients with APT-SICH with the highest risk of PR preoperatively. For the Type I and Type IIa patients, emergency surgery should be performed carefully.
format Online
Article
Text
id pubmed-8888928
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88889282022-03-03 A Novel Coagulation Classification and Postoperative Bleeding in Severe Spontaneous Intracerebral Hemorrhage Patients on Antiplatelet Therapy Liu, Qingyuan Li, Xiong Wang, Nuochuan Yang, Junhua Wang, Kaiwen Chen, Shanwen Li, Jiangan Wu, Jun Zhang, Yanan Wang, Shuo Front Aging Neurosci Aging Neuroscience BACKGROUND AND PURPOSE: For patients with severe spontaneous intracerebral hemorrhage on antiplatelet therapy (patients with APT-SICH), postoperative rebleeding (PR) is an important cause of poor outcomes after surgery. As impacted by coagulation disorder caused by APT, patients with APT-SICH are likely to suffer from PR. This study aimed to assess the risk of PR in patients with APT-SICH receiving emergency surgery using a novel coagulation classification. METHODS: This prospective, multicenter cohort study consecutively selected patients with APT-SICH between September 2019 and March 2021. The preoperative coagulation factor function was recorded, and the platelet function was assessed using thrombelastography. Based on platelet and coagulation factor function, a novel four-type coagulation classification, i.e., Type I (severe coagulation disorder), Type IIa (low platelet reserve capacity), Type IIb (normal coagulation), and Type III (hypercoagulation), was presented. The primary outcome was PR, defined as the rebleeding in the operative region or new intracerebral hemorrhage correlated with the operation. RESULTS: Of the included 197 patients with APT-SICH, PR occurred in 40 patients (20.3%). The novel coagulation classification categorized 28, 32, 122, and 15 patients into Type I, Type IIa, Type IIb, and Type III, respectively. The Type I patients had the highest incident rate of PR (39.3 per 100 persons), followed by the Type IIa patients (31.3 per 100 persons). In the PR-related analysis, the large hematoma volume (hazard ratio (HR): 1.02; 95% CI: 1.02–1.03; p < 0.001), Type I (HR: 9.72; 95% CI: 1.19–79.67; p = 0.034), and Type IIa (HR: 8.70; 95% CI: 1.09–69.61; p = 0.041) were correlated with the highest risk of PR. The coagulation classification could discriminate the PR patients from no PR (NPR) patients (p < 0.001), and it outperformed the conventional coagulation assessment (only considering platelet count and coagulation factor function) (c-statistic, 0.72 vs. 0.55). CONCLUSION: The novel coagulation classification could discriminate the patients with APT-SICH with the highest risk of PR preoperatively. For the Type I and Type IIa patients, emergency surgery should be performed carefully. Frontiers Media S.A. 2022-02-16 /pmc/articles/PMC8888928/ /pubmed/35250539 http://dx.doi.org/10.3389/fnagi.2022.793129 Text en Copyright © 2022 Liu, Li, Wang, Yang, Wang, Chen, Li, Wu, Zhang and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Aging Neuroscience
Liu, Qingyuan
Li, Xiong
Wang, Nuochuan
Yang, Junhua
Wang, Kaiwen
Chen, Shanwen
Li, Jiangan
Wu, Jun
Zhang, Yanan
Wang, Shuo
A Novel Coagulation Classification and Postoperative Bleeding in Severe Spontaneous Intracerebral Hemorrhage Patients on Antiplatelet Therapy
title A Novel Coagulation Classification and Postoperative Bleeding in Severe Spontaneous Intracerebral Hemorrhage Patients on Antiplatelet Therapy
title_full A Novel Coagulation Classification and Postoperative Bleeding in Severe Spontaneous Intracerebral Hemorrhage Patients on Antiplatelet Therapy
title_fullStr A Novel Coagulation Classification and Postoperative Bleeding in Severe Spontaneous Intracerebral Hemorrhage Patients on Antiplatelet Therapy
title_full_unstemmed A Novel Coagulation Classification and Postoperative Bleeding in Severe Spontaneous Intracerebral Hemorrhage Patients on Antiplatelet Therapy
title_short A Novel Coagulation Classification and Postoperative Bleeding in Severe Spontaneous Intracerebral Hemorrhage Patients on Antiplatelet Therapy
title_sort novel coagulation classification and postoperative bleeding in severe spontaneous intracerebral hemorrhage patients on antiplatelet therapy
topic Aging Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888928/
https://www.ncbi.nlm.nih.gov/pubmed/35250539
http://dx.doi.org/10.3389/fnagi.2022.793129
work_keys_str_mv AT liuqingyuan anovelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT lixiong anovelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT wangnuochuan anovelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT yangjunhua anovelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT wangkaiwen anovelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT chenshanwen anovelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT lijiangan anovelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT wujun anovelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT zhangyanan anovelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT wangshuo anovelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT liuqingyuan novelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT lixiong novelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT wangnuochuan novelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT yangjunhua novelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT wangkaiwen novelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT chenshanwen novelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT lijiangan novelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT wujun novelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT zhangyanan novelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy
AT wangshuo novelcoagulationclassificationandpostoperativebleedinginseverespontaneousintracerebralhemorrhagepatientsonantiplatelettherapy